Safety issues related to retroviral-mediated gene transfer in humans.

The first three approved human clinical trials utilizing retroviral-mediated gene transfer are now underway. While this technology holds great promise for the study and treatment of human disease, it also poses a number of safety concerns. In evaluating clinical protocols, potential complications and the likelihood of their occurrence are estimated by review committees so that a risk/benefit assessment can be made. Current knowledge, reviewed in this article, suggests that no acute complications secondary to retroviral-mediated gene transfer are likely, but the possibility of long-term or unforeseen sequelae in patients suggests the need for post-treatment monitoring.

[1]  F. Ledley,et al.  Correction of methylmalonyl-CoA mutase deficiency inMuto fibroblasts and constitution of gene expression in primary human hepatocytes by retroviral-mediated gene transfer , 1992, Somatic cell and molecular genetics.

[2]  A. van der Eb,et al.  Gene therapy for human inherited disorders: techniques and status. , 1992, Critical reviews in oncology/hematology.

[3]  K. Cornetta,et al.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.

[4]  K. Cornetta,et al.  Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. , 1990, Human gene therapy.

[5]  R. Sager Tumor suppressor genes: the puzzle and the promise. , 1989, Science.

[6]  R. Callahan,et al.  Mutations in human breast cancer: an overview. , 1989, Journal of the National Cancer Institute.

[7]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[8]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[9]  J. Willey,et al.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Friedmann,et al.  Progress toward human gene therapy. , 1989, Science.

[11]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[12]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[13]  A. Berns,et al.  Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.

[14]  K. Cornetta,et al.  Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. , 1989, Journal of virological methods.

[15]  E. Golemis,et al.  Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses , 1989, Journal of virology.

[16]  S. Rosenberg,et al.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.

[17]  B. Sefton,et al.  Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters , 1988, Journal of virology.

[18]  R. Mulligan,et al.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Benz,et al.  Molecular lesions involved in the progression of a human breast cancer. , 1988, Oncogene.

[20]  M. Malim,et al.  Complete nucleotide sequence of a mouse VL30 retro-element , 1988, Molecular and cellular biology.

[21]  J. Coffin,et al.  Highly preferred targets for retrovirus integration , 1988, Cell.

[22]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[23]  B. Hjelle,et al.  Transforming genes in chronic myelogenous leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Rabson,et al.  Potential progenitor sequences of mink cell focus-forming (MCF) murine leukemia viruses: ecotropic, xenotropic, and MCF-related viral RNAs are detected concurrently in thymus tissues of AKR mice , 1988, Journal of virology.

[25]  G. Shen-Ong,et al.  BALB/c Mice: Requirement of c-myb Activation but Lack of v-abl Involvement , 2022 .

[26]  J. Mietz,et al.  Nucleotide sequence of a complete mouse intracisternal A-particle genome: relationship to known aspects of particle assembly and function , 1987, Journal of virology.

[27]  T. Taniguchi,et al.  Retroviral expression of the human IL‐2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. , 1987, The EMBO journal.

[28]  P. Kantoff,et al.  Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer , 1987, The Journal of experimental medicine.

[29]  M. Nicolson,et al.  Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter , 1987, Molecular and cellular biology.

[30]  M. Bender,et al.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region , 1987, Journal of virology.

[31]  E. Golemis,et al.  Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides , 1987, Journal of virology.

[32]  R. Jaenisch,et al.  Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites , 1987, Journal of virology.

[33]  Jos Domen,et al.  The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases , 1986, Cell.

[34]  K. Isselbacher,et al.  Expression of type C-related endogenous retroviral sequences in human colon tumors and colon cancer cell lines. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Miller,et al.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.

[36]  J. Levy,et al.  The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. , 1986, Virology.

[37]  A. Miller,et al.  Factors involved in production of helper virus-free retrovirus vectors , 1986, Somatic cell and molecular genetics.

[38]  B. Sefton,et al.  Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion , 1986, Nature.

[39]  E. Krebs,et al.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.

[40]  M. Martin,et al.  Characterization of human endogenous retroviral envelope RNA transcripts , 1985, Journal of virology.

[41]  M. Martin,et al.  Nucleotide sequence of a full-length human endogenous retroviral segment , 1985, Journal of virology.

[42]  E. Linney,et al.  Suppression of leukaemia virus pathogenicity by polyoma virus enhancers , 1985, Nature.

[43]  I. Verma,et al.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene , 1985, Molecular and cellular biology.

[44]  M. Zijlstra,et al.  Involvement of c‐myc in MuLV‐induced T cell lymphomas in mice: frequency and mechanisms of activation. , 1984, The EMBO journal.

[45]  T. Hunter,et al.  Characterization of the protein apparently responsible for the elevated tyrosine protein kinase activity in LSTRA cells , 1984, Molecular and cellular biology.

[46]  W. Anderson,et al.  Prospects for human gene therapy. , 1984, The Journal of reproductive medicine.

[47]  N. Hopkins,et al.  A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus , 1984, Journal of virology.

[48]  R. Mulligan,et al.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Sorge,et al.  Amphotropic retrovirus vector system for human cell gene transfer , 1984, Molecular and cellular biology.

[50]  C. Kozak,et al.  Cellular DNA region involved in induction of thymic lymphomas (Mlvi-2) maps to mouse chromosome 15 , 1984, Molecular and cellular biology.

[51]  Wim Quint,et al.  Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region , 1984, Cell.

[52]  S. Cory,et al.  Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion , 1984, Cell.

[53]  D. Steffen Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H. Temin,et al.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors , 1983, Molecular and cellular biology.

[55]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[56]  N. Hopkins,et al.  Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[57]  E. Keshet,et al.  Conservation patterns of mouse "virus-like" (VL30) DNA sequences. , 1983, Virology.

[58]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.

[59]  T. Bonner,et al.  Cloned endogenous retroviral sequences from human DNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Schmidt,et al.  Organization and expression of endogenous virus-like (VL30) DNA sequences in nontransformed and chemically transformed mouse embryo cells in culture. , 1982, Cancer research.

[61]  D. Lowy,et al.  Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas , 1982, Nature.

[62]  M. Cole,et al.  Sequence organization of cloned intracisternal a particle genes , 1980, Cell.

[63]  K. Lueders,et al.  Intracisternal A-particle genes: identification in the genome of Mus musculus and comparison of multiple isolates from a mouse gene library. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J W Hartley,et al.  Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses , 1980, The Journal of experimental medicine.

[65]  S. Chattopadhyay,et al.  Biochemical characterization of the amphotropic group of murine leukemia viruses , 1978, Journal of virology.

[66]  E. Scolnick,et al.  Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences , 1976, Journal of virology.

[67]  R. Bassin,et al.  Isolation of murine sarcoma virus‐transormed mouse cells which are negative for leukemia virus from agar suspension cultures , 1970 .

[68]  H. Duc-Nguyen Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain) , 1968, Journal of virology.

[69]  K. Cornetta,et al.  No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. , 1991, Human gene therapy.

[70]  K. Cornetta,et al.  Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. , 1990, Human gene therapy.

[71]  A. Miller Retrovirus packaging cells. , 1990, Human gene therapy.

[72]  M. Hatzoglou,et al.  Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses. , 1990, Human gene therapy.

[73]  S. Rosenberg,et al.  Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study. , 1990, Human gene therapy.

[74]  K. Nason-Burchenal,et al.  Retrovirus-induced tumors whose development is facilitated by a chronic immune response: a comparison of two tumors committed to the monocytic lineage. , 1989, Current topics in microbiology and immunology.

[75]  W. Haseltine Development of antiviral drugs for the treatment of AIDS: strategies and prospects. , 1989, Journal of acquired immune deficiency syndromes.

[76]  L. Evans,et al.  Friend and Moloney murine leukemia viruses specifically recombine with different endogenous retroviral sequences to generate mink cell focus-forming viruses. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[77]  H. Ozer,et al.  Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors (complement fixation-immunodiffusion-neuroblastoma-plasma-cell tumor). , 1972, Proceedings of the National Academy of Sciences of the United States of America.